Career history of Reinhard Koenig
Former positions of Reinhard Koenig
Companies | Position | Start | End |
---|---|---|---|
IMCOR Pharmaceutical Co.
IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2003-03-31 | 2003-03-31 |
Public Communications Contact | 2003-03-31 | 2003-03-31 | |
Collagen Aesthetics, Inc.
Collagen Aesthetics, Inc. BiotechnologyHealth Technology Collagen Aesthetics, Inc. manufactures and markets biomedical devices for the treatment of defective, diseased, or aging human tissue | Chief Tech/Sci/R&D Officer | 1999-03-31 | 1999-03-31 |
VIVESTO AB | Chief Tech/Sci/R&D Officer | 2021-03-31 | - |
Boehringer Mannheim Corp. (California) | Chief Tech/Sci/R&D Officer | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Chief Executive Officer | 2006-02-23 | - |
President | 2006-02-23 | - | |
QUESTCOR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2004-01-31 | - |
Training of Reinhard Koenig
Philipps University of Marburg | Doctorate Degree |
Statistics
International
United States | 7 |
Germany | 2 |
Sweden | 2 |
Operational
Chief Tech/Sci/R&D Officer | 5 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VIVESTO AB | Health Technology |
Private companies | 6 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |
IMCOR Pharmaceutical Co.
IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
Collagen Aesthetics, Inc.
Collagen Aesthetics, Inc. BiotechnologyHealth Technology Collagen Aesthetics, Inc. manufactures and markets biomedical devices for the treatment of defective, diseased, or aging human tissue | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Boehringer Mannheim Corp. (California) |
- Stock Market
- Insiders
- Reinhard Koenig
- Experience